Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ATENOLOL Cause Multiple organ dysfunction syndrome? 23 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 23 reports of Multiple organ dysfunction syndrome have been filed in association with ATENOLOL (Atenolol and Chlorthalidone). This represents 0.2% of all adverse event reports for ATENOLOL.

23
Reports of Multiple organ dysfunction syndrome with ATENOLOL
0.2%
of all ATENOLOL reports
15
Deaths
14
Hospitalizations

How Dangerous Is Multiple organ dysfunction syndrome From ATENOLOL?

Of the 23 reports, 15 (65.2%) resulted in death, 14 (60.9%) required hospitalization, and 6 (26.1%) were considered life-threatening.

Is Multiple organ dysfunction syndrome Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ATENOLOL. However, 23 reports have been filed with the FAERS database.

What Other Side Effects Does ATENOLOL Cause?

Drug ineffective (1,231) Hypotension (1,121) Bradycardia (942) Completed suicide (928) Dyspnoea (791) Toxicity to various agents (742) Nausea (652) Fatigue (649) Off label use (638) Dizziness (632)

What Other Drugs Cause Multiple organ dysfunction syndrome?

TACROLIMUS (1,847) CYCLOPHOSPHAMIDE (1,597) MYCOPHENOLATE MOFETIL (1,566) PREDNISONE (1,525) DEXAMETHASONE (1,355) METHOTREXATE (1,317) METHYLPREDNISOLONE (1,278) RITUXIMAB (1,188) PREDNISOLONE (1,154) CYCLOSPORINE (933)

Which ATENOLOL Alternatives Have Lower Multiple organ dysfunction syndrome Risk?

ATENOLOL vs ATENOLOL\CHLORTHALIDONE ATENOLOL vs ATEZOLIZUMAB ATENOLOL vs ATLANTIC SALMON OIL ATENOLOL vs ATOGEPANT ATENOLOL vs ATOMOXETINE

Related Pages

ATENOLOL Full Profile All Multiple organ dysfunction syndrome Reports All Drugs Causing Multiple organ dysfunction syndrome ATENOLOL Demographics